Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT00681759
Status:
COMPLETED
Last Update Posted:
2008-10-31
First Post:
2008-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D961FC00004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Tore Lind, MD, Medical Science Director, Nexium
Old Organization:
AstraZeneca Pharmaceuticals